Introducing The Journal: Trillion Dollar Shot

Have you been puzzled by your poos or felt down about your dumps?? You’re not alone! So many of us are struggling with gut issues, which is why fiber is having a major moment. But even though we’re secretly guzzling psyllium husk, tons of us are too embarrassed to talk about our ...  Afficher plus

Collagen peptides!! Can they make you look younger and be healthier? It feels like everyone wants to be bursting with collagen, and apparently the way to do it is by scooping up that white powder of collagen peptides and guzzling it down. Do that, and — according to the wellfluen ...  Afficher plus

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ...  Afficher plus

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Afficher plus

First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ...  Afficher plus

Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats?

Links: